Table 1 Demographic and clinical data of the sample (n = 93).
Age, mean (SD), years | 57 (14) |
Gender, male/female (%) | 48 (51.6%)/45 (48.4%) |
Weight, mean (SD), kg | 80 (15) |
Height, mean (SD), cm | 166 (9.5) |
Symptoms at hospital admission, n (%) | |
Fever | 69 (74.1%) |
Myalgia | 54 (58.1%) |
Cough | 33 (35.5%) |
Dyspnoea | 31 (33.3%) |
Headache | 30 (32.2%) |
Diarrhoea | 21 (22.6%) |
Ageusia | 21 (22.6%) |
Anosmia | 18 (19.3.5%) |
Throat Pain | 12 (12.9%) |
Vomiting | 7 (7.5%) |
Medical co-morbidities at hospital admission | |
Hypertension | 32 (34.4%) |
Diabetes | 11 (11.8%) |
Cardiovascular disease | 6 (6.4%) |
Asma | 10 (10.7%) |
Obesity | 31 (33.3%) |
Chronic obstructive pulmonary disease | 4 (4.3%) |
Rheumatological disease | 4 (4.3%) |
Other (cancer, kidney disease) | 6 (6.4%) |
Stay at the hospital, mean (SD), days | 7.0 (6.2) |
Persistent post-COVID symptoms, n (%) | |
Pain symptoms | 43 (46.25%) |
Fatigue | 30 (32.2%) |
Hair loss | 24 (25.8%) |
Loss memory | 24 (25.8%) |
Anosmia | 13 (14.0%) |
Dyspnoea | 12 (12.9%) |
Brain fog | 12 (12.9%) |
Skin rashes | 10 (10.7%) |
Attention disorders | 10 (10.7%) |
Gastrointestinal disorders | 9 (9.6%) |
Tachycardia-palpitations | 9 (9.6%) |
Ageusia | 9 (9.6%) |
Ocular/vision disorders | 8 (8.6%) |
Throat pain | 7 (7.5%) |
Diarrhoea | 5 (5.3%) |
Cough | 2 (2.1%) |
